The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settings

In a Policy Forum, Peter Ehrenkranz and colleagues discuss the contribution of CD4 and viral load testing to outcomes for people with HIV in low- and middle-income countries.

Saved in:
Bibliographic Details
Published in:PLoS medicine 2019-05, Vol.16 (5), p.e1002820-e1002820
Main Authors: Ehrenkranz, Peter D, Baptiste, Solange L, Bygrave, Helen, Ellman, Tom, Doi, Naoko, Grimsrud, Anna, Jahn, Andreas, Kalua, Thokozani, Nyirenda, Rose Kolola, Odo, Michael O, Ondoa, Pascale, Vojnov, Lara, Holmes, Charles B
Format: Article
Language:English
Subjects:
Acquired immune deficiency syndrome
AIDS
Anti-HIV Agents - therapeutic use
Antiretroviral drugs
Biology and Life Sciences
Care and treatment
CD4 antigen
CD4 Lymphocyte Count
Charities
Clinical outcomes
Collaboration
Developing Countries - economics
Drug therapy
Feasibility studies
Global health
Global Health - economics
Health Care Costs
Health Services Accessibility
HIV
HIV - drug effects
HIV - growth & development
HIV - immunology
HIV Infections - diagnosis
HIV Infections - drug therapy
HIV Infections - immunology
HIV Infections - virology
HIV patients
Human immunodeficiency virus
Humans
Medical laboratories
Medical research
Medicine and Health Sciences
Mortality
Patients
Policy Forum
Predictive Value of Tests
Prognosis
Research and Analysis Methods
Risk Factors
Social Sciences
Systematic review
Viral Load
White blood cells
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In a Policy Forum, Peter Ehrenkranz and colleagues discuss the contribution of CD4 and viral load testing to outcomes for people with HIV in low- and middle-income countries.
ISSN:1549-1676
1549-1277
1549-1676
DOI:10.1371/journal.pmed.1002820